DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
DMZPY
DexCom
DXCM
Hutchmed (China)
HCM
New Fortress Energy
NFE
Enerpac Tool
EPAC
US Stock MarketDetailed Quotes
ALGS Aligos Therapeutics
- 23.670
- +2.660+12.66%
Close Feb 14 16:00 ET
- 22.550
- -1.120-4.73%
Post 20:01 ET
84.93MMarket Cap-3.26P/E (TTM)
23.730High20.537Low307.01KVolume21.130Open21.010Pre Close6.92MTurnover17.97%Turnover RatioLossP/E (Static)3.59MShares46.80052wk High1.70P/B40.45MFloat Cap6.76052wk Low--Dividend TTM1.71MShs Float937.748Historical High--Div YieldTTM15.20%Amplitude6.760Historical Low22.555Avg Price1Lot Size
About Aligos Therapeutics Company
Aligos Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which is engaged in in developing therapeutics for chronic liver diseases and viral infections. The firm is focused on the discovery and development of targeted antiviral therapies for chronic hepatitis B (CHB) and coronaviruses, as well as leveraging its expertise in liver diseases to create targeted therapeutics for nonalcoholic steatohepatitis (NASH). The company was founded by Lucinda Quan and Lawrence M. Blatt on February 05, 2018 and is headquartered in South San Francisco, CA.
Company Profile
SymbolALGS
Company NameAligos Therapeutics
Listing DateOct 16, 2020
Issue Price15.00
Founded2018
CEODr. Lawrence M. Blatt,PhD
MarketNASDAQ
Employees66
Fiscal Year Ends12-31
Address1 Corporate Drive,2nd floor
CitySouth San Francisco
ProvinceCalifornia
CountryUnited States of America
Zip Code94080
Phone1-800-466-6059
Websitehttp://www.aligos.com
Company Executives
- Name
- Position
- Salary
- Dr. Lawrence M. Blatt,PhD
- President, Chairman of the Board and Chief Executive Officer
- 1.34M
- Julian A. Symons, D.Phil.
- Executive Vice President and Chief Scientific Officer
- 836.32K
- Lesley Ann Calhoun
- Chief Operating Officer, Executive Vice President, Chief Financial Officer and Principal Accounting Officer
- --
- Dr. Heather Elizabeth Preston, M.D.
- Director
- --
- Margarita Chavez, J.D.
- Director
- --
- Dr. Bridget A. Martell, M.D.
- Independent Director
- 52.90K
- Dr. K. Peter Hirth, PhD
- Independent Director
- 60.40K
- Carole L. Nuechterlein, J.D.
- Independent Director
- 12.90K
- James Scopa
- Independent Director
- 67.90K
